Location History:
- Witney, GB (2006)
- Oxford, GB (2007 - 2012)
Company Filing History:
7 out of 16 
6 out of 2,538 
2 out of 3 Years Active: 2006-2025
Title: Biography of Matthew Colin Thor Fyfe
Introduction: Matthew Colin Thor Fyfe is an accomplished inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target G-protein coupled receptors.
Latest Patents: Fyfe holds 13 patents, with his latest innovations focusing on heterocyclic derivatives as GPCR receptor agonists. These compounds are designed to regulate satiety and are useful in the treatment of obesity and diabetes. His work includes compounds of Formula (I), R-A-V—B—R, and their pharmaceutically acceptable salts, which act as agonists of GPR116.
Career Highlights: Throughout his career, Fyfe has worked with notable companies such as Prosidion Limited and Warner-Lambert Company. His expertise in pharmacology and receptor biology has positioned him as a key figure in the development of new therapeutic agents.
Collaborations: Fyfe has collaborated with esteemed colleagues, including Martin James Procter and Vilasben Kanji Shah. These partnerships have enhanced his research and contributed to the advancement of innovative solutions in the pharmaceutical industry.
Conclusion: Matthew Colin Thor Fyfe's work exemplifies the impact of innovation in medicine. His patents and collaborations reflect a commitment to addressing critical health issues, particularly obesity and diabetes, through scientific research and development.